American Equity Investment Life (AEL) Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for American Equity Investment Life in the last year. There are currently 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEL, but not buy additional shares or sell existing shares.
View AEL analyst ratings or view top-rated stocks.

8 brokerages have issued 1-year price targets for American Equity Investment Life's stock. Their AEL share price forecasts range from $43.00 to $55.00. On average, they anticipate the company's share price to reach $47.38 in the next twelve months. This suggests that the stock has a possible downside of 11.8%.
View analysts price targets for AEL or view top-rated stocks among Wall Street analysts.

American Equity Investment Life's stock was trading at $45.62 at the beginning of the year. Since then, AEL stock has increased by 17.8% and is now trading at $53.74.
View the best growth stocks for 2023 here.

American Equity Investment Life saw a increase in short interest in August. As of August 31st, there was short interest totaling 1,560,000 shares, an increase of 5.4% from the August 15th total of 1,480,000 shares. Based on an average daily trading volume, of 792,300 shares, the short-interest ratio is presently 2.0 days. Approximately 2.0% of the shares of the stock are short sold.
View American Equity Investment Life's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our AEL earnings forecast.

American Equity Investment Life Holding (NYSE:AEL) issued its earnings results on Monday, August, 7th. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.65 by $0.03. The financial services provider had revenue of $851.60 million for the quarter, compared to the consensus estimate of $646.06 million. American Equity Investment Life had a trailing twelve-month return on equity of 15.52% and a net margin of 18.55%. American Equity Investment Life's revenue for the quarter was up 600.3% compared to the same quarter last year. During the same period last year, the business posted $0.98 EPS.

American Equity Investment Life declared an annual dividend on Thursday, November 17th. Shareholders of record on Monday, November 28th will be paid a dividend of $0.02 per share on Tuesday, December 13th. This represents a yield of 0.05%. The ex-dividend date of this dividend is Friday, November 25th.
Read our dividend analysis for AEL.

ETFs with the largest weight of American Equity Investment Life (NYSE:AEL) stock in their portfolio include Adaptive Core ETF (RULE), ProShares Merger ETF (MRGR), SPDR S&P Insurance ETF (KIE), Invesco S&P SmallCap Quality ETF (XSHQ), Cambria Value and Momentum ETF (VAMO), Invesco S&P SmallCap Financials ETF (PSCF), Invesco S&P SmallCap Value with Momentum ETF (XSVM) and Royce Quant Small-Cap Quality Value ETF (SQLV).

American Equity Investment Life (NYSE:AEL) pays an annual dividend of $0.02 per share and currently has a dividend yield of 0.04%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 0.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AEL will have a dividend payout ratio of 0.29% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for AEL.

2 employees have rated American Equity Investment Life Chief Executive Officer Anant Bhalla on Glassdoor.com. Anant Bhalla has an approval rating of 100% among the company's employees. This puts Anant Bhalla in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other American Equity Investment Life investors own include Energy Transfer (ET), Extreme Networks (EXTR), Neos Therapeutics (NEOS), Neurotrope (NTRP), Pfizer (PFE), Activision Blizzard (ATVI), Bank of America (BAC), Chimerix (CMRX), Lam Research (LRCX) and Nasdaq (NDAQ).

American Equity Investment Life trades on the New York Stock Exchange (NYSE) under the ticker symbol "AEL."

American Equity Investment Life's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (13.75%), Dimensional Fund Advisors LP (8.21%), State Street Corp (3.58%), Clearbridge Investments LLC (3.24%), Goldman Sachs Group Inc. (2.66%) and Geode Capital Management LLC (1.93%). Insiders that own company stock include Alan David Matula, Anant Bhalla, Axel Andre, Gerard D Neugent, James Louis Hamalainen, Jeffrey D Lorenzen, John M Matovina, Joyce Ann Chapman, Robert L Howe, Ronald James Grensteiner and Ted Morris Johnson.
View institutional ownership trends.

Shares of AEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEL stock can currently be purchased for approximately $53.74.

American Equity Investment Life (NYSE:AEL) has a market capitalization of $4.21 billion and generates $1.42 billion in revenue each year. The financial services provider earns $1.22 billion in net income (profit) each year or $5.43 on an earnings per share basis.

The company employs 840 workers across the globe.

American Equity Investment Life's mailing address is 6000 Westown Parkway, West Des Moines IA, 50266. The official website for the company is www.american-equity.com. The financial services provider can be reached via phone at (515) 221-0002, via email at sschwartz@american-equity.com, or via fax at 515-221-9947.